Search for a trial

A Phase 3 Open-label Extension Study to Assess the Long-term Safety and Efficacy of
Intravenous ATB200 Co-administered With Oral AT2221 in Adult Subjects With Late-onset Pompe
Disease

This study has been transitioned to CTIS with ID 2023-505170-15-00 check the CTIS register for the current data. The objective of the study is to assess the long-term safety and efficacy of intravenous ATB200 co-administration with oral AT2221 in…